Global Factor IX Complex Concentrate Market Growth 2024-2030

Factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.

The global Factor IX Complex Concentrate market size is projected to grow from US$ 1029 million in 2024 to US$ 2081 million in 2030; it is expected to grow at a CAGR of 12.4% from 2024 to 2030.

ReportPrime's newest research report, the “Factor IX Complex Concentrate Industry Forecast” looks at past sales and reviews total world Factor IX Complex Concentrate sales in 2023, providing a comprehensive analysis by region and market sector of projected Factor IX Complex Concentrate sales for 2024 through 2030. With Factor IX Complex Concentrate sales broken down by region, market sector, and sub-sector, this report provides a detailed analysis in US$ millions of the world Factor IX Complex Concentrate industry.

This Insight Report provides a comprehensive analysis of the global Factor IX Complex Concentrate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Factor IX Complex Concentrate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Factor IX Complex Concentrate market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Factor IX Complex Concentrate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Factor IX Complex Concentrate.

United States market for Factor IX Complex Concentrate is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Factor IX Complex Concentrate is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Factor IX Complex Concentrate is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Factor IX Complex Concentrate players cover CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Factor IX Complex Concentrate market by product type, application, key manufacturers, and key regions and countries.

Segmentation by Type:

• Beriplex
• Profilnine
• Octaplex
• Prothromplex
• Cofact
• Other

Segmentation by Application:

• Hemophilia B
• Acquired Coagulation Factor Deficiency

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• CSL Behring
• Grifols
• Octapharma
• Prothya Biosolutions
• Takeda

Key Questions Addressed in this Report

1. What is the 10-year outlook for the global Factor IX Complex Concentrate market?
2. What factors are driving Factor IX Complex Concentrate market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do Factor IX Complex Concentrate market opportunities vary by end market size?
5. How does Factor IX Complex Concentrate break out by Type, by Application?